Director, National Payer Accounts
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Posted Sep 22, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 16, 2026
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $240K-$275K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, National Payer Accounts Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: Position Overview: - The Director, National Payer Accounts, is responsible for ensuring profitable coverage access with government accounts and key regional plans. - Supporting execution of the Market Access objectives and strategy for the payer audience. - Collaborating with internal partners but not limited to Market Access, Marketing, Commercial Operations, Sales and Medical to align approaches with our largest customers to ensure the best patient and provider experience. Responsibilities: - Execute specific customer strategy as it aligns with the overall product and organizational goals. - Deliver the value of our products, services and the Cogent organization by managing interactions with all customer stakeholders. - Develop and execute corporate strategies customized to the market access payer
Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Director, Accounting Operations
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Director, Managed Markets—National Accounts
BridgeBio Pharma, Inc. - Remote - USA
National Account Director - Payers
Regeneron Pharmaceuticals - Remote - United States
Director, National Accounts
Danaher Corporation - Chicago, Illinois, United States of America